Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Stomach Neoplasms × Automobiles × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Stomach Neoplasms 1 Breast Neoplasms 1

Interventions

vactosertib 1 titanium silicide 1 fludarabine phosphate 1 aldesleukin 1 S 1 (combination) 1 Receptors, Chimeric Antigen 1 Oxaliplatin 1 Interleukin-2 1 Infusions, Parenteral 1 IL32 protein, human 1 Hyperthermic Intraperitoneal Chemotherapy 1 Drug Therapy 1 Docetaxel 1 Cyclophosphamide 1 Capecitabine 1 Automobiles 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04650451 2023-04-20

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

Bellicum Pharmaceuticals

Phase 1 Suspended

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡